Skye Bioscience, Inc. Common Stock (SKYE) — Free Cash Flow Generation Index

Latest as of June 2014: -7.56x

Skye Bioscience, Inc. Common Stock (SKYE) has a Free Cash Flow Generation Index of -7.56x as of June 2014. Free cash flow of $-59.91K represents -8% of operating cash flow ($7.92K). Explore Skye Bioscience, Inc. Common Stock (SKYE) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-7.56x
Free Cash Flow / Operating CF

Free Cash Flow

$-59.91K
USD

Operating Cash Flow

$7.92K
USD

Capital Expenditures

$67.83K
USD

Skye Bioscience, Inc. Common Stock Free Cash Flow Generation Index (2012–2012)

Historical FCF Generation Index trend for Skye Bioscience, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see SKYE cash flow metrics.

Annual Free Cash Flow Generation for Skye Bioscience, Inc. Common Stock (2012–2012)

Year-by-year Free Cash Flow Generation Index for Skye Bioscience, Inc. Common Stock. Check cash flow reinvestment rate of Skye Bioscience, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2012 1.00x $1.93K $1.93K $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).